疏血通注射液治疗糖尿病患者下肢动脉硬化闭塞症的有效性
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Efficacy of Shuxuetong In jectionin the Treatment of Arterios Clerosis Obliterans of Lower Extremitiesin Patientswith Diabetes Mellitus
  • 作者:石雪飞
  • 英文作者:SHI Xuefei;Dongying Victory Organ Hospital Department of Internal Medicine;
  • 关键词:疏血通注射液 ; 糖尿病 ; 下肢动脉硬化闭塞症
  • 英文关键词:Shu xue tonginjection;;Diabetes mellitus;;Lower extremity arteriosclerosis obliterans
  • 中文刊名:SZBJ
  • 英文刊名:Biped and Health
  • 机构:东营胜利机关医院内科;
  • 出版日期:2019-04-01
  • 出版单位:双足与保健
  • 年:2019
  • 期:v.28;No.213
  • 语种:中文;
  • 页:SZBJ201907046
  • 页数:2
  • CN:07
  • ISSN:11-3086/R
  • 分类号:98-99
摘要
目的分析将疏血通注射液应用到糖尿病导致的下肢动脉硬化闭塞症患者中的治疗效果。方法 2017年1月—2018年12月,从该院选取50例糖尿病下肢动脉硬化闭塞症患者作为研究对象,随机均匀分组,组别可分为对照组(25例)与观察组(25例),在对照组中应用前列地尔,观察组中应用疏血通注射液。结果对照组和观察组患者的治疗总有效率分别为64.00%、92.00%,观察组的治疗总有效率显著高于对照组,差异有统计学意义(P<0.05)。结论将疏血通注射液应用到糖尿病导致的下肢动脉硬化闭塞症患者中的效果显著。
        Objective To analyze the therapeutic effect of Shuxuetong injection on lower extremity arteriosclerosis obliterans caused by diabetes mellitus. Methods From January 2017 to December 2018, 50 patients with diabetic lower extremity arteriosclerosis obliterans were randomly and evenly divided into control group(25 cases) and observation group(25 cases). Alprostadil was used in control group and Shuxuetong injection was used in observation group. Results The total effective rates of the control group and the observation group were 64.00% and 92.00%, respectively. The total effective rates of the observation group were significantly higher than those of the control group(P <0.05). Conclusion Shuxuetong injection is effective in treating lower extremity arteriosclerosis obliterans caused by diabetes mellitus.
引文
[1]姜淑凤,艾发元,苗志勃,等.疏血通注射液股动脉加压灌注治疗Ⅱ期下肢动脉硬化闭塞症60例临床观察[J].河北中医,2012,34(4):573-575.
    [2]冯琨,谭静范,陈影,等.疏血通注射液治疗糖尿病下肢动脉硬化闭塞症临床观察[J].中国中西医结合杂志,2009,29(3):255-257.
    [3]刘莉.疏血通注射液治疗糖尿病患者下肢动脉硬化闭塞症的有效性[J].中医临床研究,2015,7(28):91-92.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700